KT Medical Service PCL (BKK:KTMS)
Thailand flag Thailand · Delayed Price · Currency is THB
1.210
-0.010 (-0.82%)
Sep 3, 2026, 4:36 PM ICT

KT Medical Service PCL Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
711.71703.84596.8456.11377.63309.37
Other Revenue
3.213.423.874.426.523.43
714.92707.27600.67460.52384.14312.8
Revenue Growth
6.93%17.75%30.43%19.88%22.81%46.47%
Cost of Revenue
579.65571.29500.75373.46305.79247.15
Gross Profit
135.27135.9899.9287.0778.3565.66
Selling, General & Admin
83.5775.8573.7766.7554.6639.92
Operating Expenses
83.1375.0973.3866.8549.7140.14
Operating Income
52.1360.8926.5420.2228.6525.51
Interest Expense
-6.47-5.81-3.45-2.83-3.53-5.68
Interest & Investment Income
0.951.121.231.060.940.99
Pretax Income
46.6156.224.3218.4526.0620.82
Income Tax Expense
10.6112.115.864.864.964.02
Earnings From Continuing Operations
3644.0918.4613.5921.116.8
Minority Interest in Earnings
0.120.270.70.620.08-
Net Income
36.1144.3619.1614.2121.1816.8
Net Income to Common
36.1144.3619.1614.2121.1816.8
Net Income Growth
14.69%131.50%34.85%-32.92%26.05%-
Shares Outstanding (Basic)
300300300300227181
Shares Outstanding (Diluted)
300300300300227181
Shares Change
-0.08%--32.28%25.21%75.16%
EPS (Basic)
0.120.150.060.050.090.09
EPS (Diluted)
0.120.150.060.050.090.09
EPS Growth
14.78%131.50%34.85%-49.29%0.67%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-5.56-24.29-3.78-143.5-45.06-40.07
Free Cash Flow Per Share
-0.02-0.08-0.01-0.48-0.20-0.22
Dividend Per Share
0.0130.0130.0230.0140.033-
Dividend Growth
-44.21%-44.21%66.43%-57.19%--
Gross Margin
18.92%19.23%16.63%18.91%20.40%20.99%
Operating Margin
7.29%8.61%4.42%4.39%7.46%8.16%
Profit Margin
5.05%6.27%3.19%3.08%5.51%5.37%
Free Cash Flow Margin
-0.78%-3.43%-0.63%-31.16%-11.73%-12.81%
EBITDA
96.22102.4662.1143.9846.241.13
EBITDA Margin
13.46%14.49%10.34%9.55%12.03%13.15%
D&A For EBITDA
44.0941.5735.5723.7617.5515.62
EBIT
52.1360.8926.5420.2228.6525.51
EBIT Margin
7.29%8.61%4.42%4.39%7.46%8.16%
Effective Tax Rate
22.76%21.55%24.11%26.33%19.02%19.29%
Revenue as Reported
715.86708.39601.9461.58385.08313.79